| Literature DB >> 7507036 |
J Elia1.
Abstract
Attention deficit hyperactivity disorder (ADHD) is a common childhood behavioural disorder and medication is one of the principal treatments. Methylphenidate and dexamphetamine (dextroamphetamine) have a long record of use in children and well proven efficacy, and are the preferred drugs. Current clinical guidelines recommend a trial of methylphenidate and of dexamphetamine for each child meeting criteria for the disorder in order to maximise response rate and minimise adverse effects.Entities:
Mesh:
Substances:
Year: 1993 PMID: 7507036 DOI: 10.2165/00003495-199346050-00006
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546